- Country: South Korea
- Summary: Development of Effective Neutralizing Antibody Assay Method for Immunogenicity Analysis of Polio and Chickenpox Vaccines
- KRT Ref No: 50028062
- Deadline: 23 Mar 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 727272727
- Notice Type: Tender
- Document Ref. No.: 20210212145-00
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Development of efficient neutralizing antibody assay method for immunogenicity analysis of polio and chickenpox vaccines
Reference number: Korea Centers for Disease Control and Prevention, National Institute of Health Notice No. 2021-22 Allocation budget: 800,000,000 won
Estimated price: KRW 727,272,727
Bidding start date and time: 2021/02/09 10:00:00
Bidding deadline: 2021/03/23 10:00:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDevelopment of Effective Neutralizing Antibody Assay Method for Immunogenicity Analysis of Polio and Chickenpox Vaccines - Korea Tender
The NATIONAL INSTITUTE OF HEALTH RESEARCH, KOREA CENTERS FOR DISEASE CONTROL AND PREVENTION, a Government sector organization in South Korea, has announced a new tender for Development of Effective Neutralizing Antibody Assay Method for Immunogenicity Analysis of Polio and Chickenpox Vaccines. This tender is published on KoreaTenders under KRT Ref No: 50028062 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-03-23.
The estimated tender value is KRW 727272727, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
